Cargando…

817. Caspofungin versus Anidulafungin in Patients with Candidemia: Retrospective Comparative Study

BACKGROUND: Echinocandins are recommended as initial treatment for candidemia. The safety and efficacy of both anidulafungin and caspofungin are well established, yet; no direct comparison was made pertaining to their efficacy and safety. This was a retrospective study to compare efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elajez, Reem, Bakdach, Dana, Al Balushi, Sara, Abdallah, Tasneem, Zaqout, Ahmed, Alattar, Rand, Awouda, Waleed, Wilson, Godwin, Alsoub, Hussam Abdelrahman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679046/ http://dx.doi.org/10.1093/ofid/ofad500.862

Ejemplares similares

Anidulafungin Versus Micafungin in the Treatment of Candidemia in Adult Patients
por: Suh, Jin Woong, et al.
Publicado: (2020)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature
por: Glöckner, A
Publicado: (2011)

1412. Caspofungin and Anidulafungin Behave as Fungistatic Agents Against Candida auris
por: Dudiuk, Catiana, et al.
Publicado: (2018)

Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients
por: Ruhnke, M, et al.
Publicado: (2011)

375. Tolerability of Anidulafungin for Candidemia in Patients With Hepatic or Renal Dysfunction
por: Kim, Ji Young, et al.
Publicado: (2018)

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature
por: Kofla, G, et al.
Publicado: (2011)

Caspofungin-Induced Cardiotoxicity in Patients Treating for Candidemia
por: Sattarzadeh Badkoubeh, Roya, et al.
Publicado: (2022)

In Vitro Interaction and Killing-Kinetics of Amphotericin B Combined with Anidulafungin or Caspofungin against Candida auris
por: Caballero, Unai, et al.
Publicado: (2021)

Hospital pharmacists’ self-evaluation of their competence and confidence in conducting pharmacy practice research
por: Awaisu, Ahmed, et al.
Publicado: (2015)

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in the Treatment of HIV-Infected Patients: Experience with the First 100 Patients from Qatar
por: Al Soub, Hussam, et al.
Publicado: (2020)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs - review of the literature
por: Wilke, MH
Publicado: (2011)

Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation
por: Bakdach, Dana, et al.
Publicado: (2022)

Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species
por: Tóth, Zoltán, et al.
Publicado: (2020)

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
por: Gebretekle, Gebremedhin Beedemariam, et al.
Publicado: (2022)

Labeling of penicillin allergy in patients admitted to a tertiary hospital in Qatar: A retrospective audit
por: Hasan Elajez, Reem, et al.
Publicado: (2022)

Retrospective review of medication allergy labeling among patients admitted to a tertiary hospital in Qatar
por: Al-Adawi, Rana M., et al.
Publicado: (2023)

2111. Anidulafungin vs. Micafungin Treatment in Adult Patients with Candidemia: A Retrospective Study of Single-Center Experience
por: Suh, Jinwoong, et al.
Publicado: (2019)

Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia
por: Roilides, Emmanuel, et al.
Publicado: (2020)

Cost-effectiveness analysis and budgetary impact of anidulafungin treatment for patients with candidemia and other forms of invasive candidiasis in Brazil
por: Vianna, Cid Manso de Mello, et al.
Publicado: (2023)

Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report
por: Omrani, Ali S., et al.
Publicado: (2020)

Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum
por: Kovács, Renátó, et al.
Publicado: (2021)

1242. Efficacy and Safety of Intravenous Fosfomycin for the Treatment of Multi-resistant Gram Negative Infections
por: Abdallah, Tasneem, et al.
Publicado: (2021)

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
por: Kett, Daniel H, et al.
Publicado: (2011)

Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial
por: Mootsikapun, Piroon, et al.
Publicado: (2013)

Französische Suiten, BWV 812-817 French suites = Suites françaises /
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1995)

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
por: Reboli, Annette C, et al.
Publicado: (2011)

Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study
por: Sinnollareddy, Mahipal G, et al.
Publicado: (2015)

Candidemia in children after complex congenital heart defects surgery treated with caspofungin – our own experience and a review of literature
por: Jaworski, Radoslaw, et al.
Publicado: (2011)

Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial
por: Thompson, George R, et al.
Publicado: (2020)

Anidulafungin in the treatment of invasive fungal infections
por: Sabol, Kathryn, et al.
Publicado: (2008)

Anidulafungin and its role in candida infections
por: Cappelletty, Diane M, et al.
Publicado: (2009)

Pharmacokinetics of anidulafungin during albumin dialysis
por: Aguilar, Gerardo, et al.
Publicado: (2014)

Does Weight Impact Anidulafungin Pharmacokinetics?
por: Lempers, Vincent J., et al.
Publicado: (2016)

Anidulafungin: Lack of efficacy: case report
Publicado: (2022)

Erratum to: Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-Blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial
Publicado: (2021)

French suites nos. 3-6, BWV 814-817
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1994)

Breast Cancer in Men: Clinical and Pathological Analysis of 817 Cases
por: Spreafico, Fernanda Servidoni, et al.
Publicado: (2020)

Invasive Fungal Infections in Infants—Focus on Anidulafungin
por: Wilke, Michael H.
Publicado: (2013)

Cost-effectiveness analysis of anidulafungin in the treatment of candidaemia
por: Auzinger, G, et al.
Publicado: (2013)

Anidulafungin/voriconazole: Lack of efficacy: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rtvf986vrudr4ldf3hcvc10kvk